NewsBenzinga60 디그리스 파마슈티컬스, 10월 6일 타페노퀸 임상시험 중간 분석 데이터 발표 예정 60 디그리스 파마슈티컬스, 10월 6일 타페노퀸 임상시험 중간 분석 데이터 발표 예정 Benzinga 2026.10.01 12:12 (GMT+0) Open on Benzinga Other news Wells Fargo Maintains Equal-Weight on Sonoco Products, Lowers Price Target to $53 Piper Sandler Maintains Neutral on WaFd, Lowers Price Target to $31 VinFast Says Real Estate Could Cover Its EV Cash Burn Wells Fargo Maintains Overweight on Silgan Hldgs, Lowers Price Target to $52 Piper Sandler Maintains Neutral on First Finl Bankshares, Lowers Price Target to $33 $1000 Invested In Extra Space Storage 20 Years Ago Would Be Worth This Much Today
